ContractClinical Trial Agreement • February 27th, 2024
Contract Type FiledFebruary 27th, 2024AM ENTM ENT # 2 TO THE CLINICAL TRIAL AGREEM ENT PROTOCOL # 68284528M M Y3004 DODATEK 2 KE SM LOUVĚ O KLINICKÉM HODNOCENÍ PROTOKOL # 68284528M M Y3004 This Amendment #2 (“ Amendment”) to the Clinical TrialAgreement (“ Agreement” ) shall enter into effect on and effective as of the date of publication into the Register of Tento dodatek číslo 2 (dodatek) ke smlouvě o klinickém hodnocení („smlouva“) je účinný k datu uveřejněnív Registru smluv České republiky („ datum účinnosti“) Cont racts in the Czech Republic (“ Effective Date” ) Between Uzavřený mezi Janssen – Cilag International N.V.,with registered offices at: Turnhoutseweg 30, 2340 Beerse, BelgiumRegistration No.: BE0461607459Represented by the Power of Attorney by the companyJanssen-Cilag s.r.o.with registered offices at Walterovo náměstí 329/ 1, 158 00 Praha 5 – Jinonice, Czech RepublicID No.: 27146928 Tax ID: CZ27146928Registered in the Com mercial Register at the M unicipal Court in Prague, section C, enclosure 99837Bank det